Effects of CP-060S, a Novel Cardioprotective Drug, on Cardiac Function and Myocardial Oxygen Consumption
- 1 January 1999
- journal article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 32 (1) , 57-63
- https://doi.org/10.1016/s0306-3623(98)00062-7
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The protective effects of CP-060S on ischaemia- and reperfusion-induced arrhythmias in anaesthetized ratsBritish Journal of Pharmacology, 1998
- CP-060S, a Novel Cardioprotective Drug, Limits Myocardial Infarct Size in Anesthetized DogsJournal of Cardiovascular Pharmacology, 1998
- CP-060S interacts with three principal binding sites on the L-type Ca2+ channelEuropean Journal of Pharmacology, 1998
- Antianginal effects of CP-060S, a novel cardioprotective drug, in a methacholine-induced ECG change model in ratsThe Japanese Journal of Pharmacology, 1998
- Effects of CP-060S on membrane channels in vascular smooth muscle cells from guinea pigEuropean Journal of Pharmacology, 1997
- Actions of CP-060S on veratridine-induced Ca2+ overload in cardiomyocytes and mechanical activities in vascular stripsEuropean Journal of Pharmacology, 1996
- R56865, an antiarrhythmic drug with class III effects that terminates ouabain induced ventricular tachycardia in an inverse rate dependent mannerCardiovascular Research, 1993
- Inhibition of sodium and calcium overload pathology in the myocardium: a new cytoprotective principleCardiovascular Research, 1993
- Effects of R 56 865, a Preventer of Cellular Calcium Overload, on Left Ventricular Diastolic Properties During Pacing-Induced Ischemia in DogsJournal of Cardiovascular Pharmacology, 1991
- Differences in cardiovascular profile among calcium antagonistsThe American Journal of Cardiology, 1987